Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126774942 | 12677494 | 2 | F | 20160823 | 20160823 | 20160826 | EXP | JP-PFIZER INC-2016391451 | PFIZER | SAITO, J.. THERAPEUTIC DRUG MONITORING OF GANCICLOVIR FOR POST-LIVER TRANSPLANT PEDIATRIC PATIENT WITH MASSIVE ASCITES AND RENAL FAILURE. JAPANESE JOURNAL OF MEDICINE AND PHARMACEUTICAL SCIENCE. 2016;73(8):1025 | 4.00 | YR | M | Y | 0.00000 | 20160826 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126774942 | 12677494 | 1 | PS | FLUCONAZOLE. | FLUCONAZOLE | 1 | UNK | U | 19949 | ||||||||||
| 126774942 | 12677494 | 2 | SS | MEROPENEM. | MEROPENEM | 1 | UNK | U | 90940 | ||||||||||
| 126774942 | 12677494 | 3 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 10 MG/KG, UNK | U | 11153 | 10 | MG/KG | ||||||||
| 126774942 | 12677494 | 4 | SS | METRONIDAZOLE. | METRONIDAZOLE | 1 | Intravenous (not otherwise specified) | UNK | U | 18353 | SOLUTION FOR INFUSION | ||||||||
| 126774942 | 12677494 | 5 | SS | PIPERACILLIN/TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | UNK | U | 50684 | ||||||||||
| 126774942 | 12677494 | 6 | SS | PIPERACILLIN/TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | U | 50684 | |||||||||||
| 126774942 | 12677494 | 7 | SS | CEFTAZIDIME. | CEFTAZIDIME | 1 | UNK | Y | 0 | ||||||||||
| 126774942 | 12677494 | 8 | SS | GENTAMICIN. | GENTAMICIN | 1 | UNK | Y | 0 | ||||||||||
| 126774942 | 12677494 | 9 | SS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | UNK | Y | 0 | ||||||||||
| 126774942 | 12677494 | 10 | SS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | Y | 0 | |||||||||||
| 126774942 | 12677494 | 11 | SS | AMPHOTERICIN B, LIPOSOME | AMPHOTERICIN B | 1 | UNK | Y | 0 | ||||||||||
| 126774942 | 12677494 | 12 | SS | ATG /00575401/ | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126774942 | 12677494 | 1 | Candida infection |
| 126774942 | 12677494 | 2 | Pseudomonas infection |
| 126774942 | 12677494 | 4 | Bacterial translocation |
| 126774942 | 12677494 | 5 | Pyrexia |
| 126774942 | 12677494 | 6 | Device related sepsis |
| 126774942 | 12677494 | 7 | Peritonitis |
| 126774942 | 12677494 | 8 | Pseudomonas infection |
| 126774942 | 12677494 | 9 | Pyrexia |
| 126774942 | 12677494 | 10 | Device related sepsis |
| 126774942 | 12677494 | 11 | Fungaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126774942 | 12677494 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126774942 | 12677494 | Bacterial infection | |
| 126774942 | 12677494 | Bone marrow failure | |
| 126774942 | 12677494 | Clostridium difficile colitis | |
| 126774942 | 12677494 | Device related infection | |
| 126774942 | 12677494 | Drug ineffective | |
| 126774942 | 12677494 | Fungal infection | |
| 126774942 | 12677494 | Graft versus host disease | |
| 126774942 | 12677494 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |